Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients and siphoning money away from Medicaid, according ...
It's one of the top healthcare stocks in my portfolio. If I didn't already own this biotech stock, I wouldn't hesitate to buy ...
The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...
Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...
ASUS is one of the world's largest computer hardware companies. Its products include desktops, PC peripherals, laptops, smartphones, tablets and hybrid devices. The company has made Android phones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback